[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Amneal Pharmaceuticals Inc (AMRX)

Amneal Pharmaceuticals Inc (AMRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,035,641
  • Shares Outstanding, K 319,023
  • Annual Sales, $ 3,019 M
  • Annual Income, $ 72,060 K
  • EBIT $ 434 M
  • EBITDA $ 680 M
  • 60-Month Beta 1.30
  • Price/Sales 1.36
  • Price/Cash Flow 8.26
  • Price/Book N/A

Options Overview Details

View History
  • Implied Volatility 76.09% (+5.18%)
  • Historical Volatility 28.75%
  • IV Percentile 40%
  • IV Rank 42.44%
  • IV High 175.93% on 03/30/26
  • IV Low 2.47% on 09/09/25
  • Expected Move (DTE 15) 0.81 (6.27%)
  • Put/Call Vol Ratio 0.24
  • Today's Volume 63
  • Volume Avg (30-Day) 62
  • Put/Call OI Ratio 0.83
  • Today's Open Interest 2,687
  • Open Int (30-Day) 3,587
  • Expected Range 12.07 to 13.69

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $0.24
  • Number of Estimates 1
  • High Estimate $0.24
  • Low Estimate $0.24
  • Prior Year $0.23
  • Growth Rate Est. (year over year) +4.35%

Price Performance

See More
Period Period Low Period High Performance
1-Month
11.76 +9.48%
on 05/19/26
13.84 -6.97%
on 05/07/26
+0.05 (+0.35%)
since 05/01/26
3-Month
11.71 +9.95%
on 03/24/26
13.92 -7.51%
on 04/20/26
-0.44 (-3.27%)
since 03/03/26
52-Week
7.07 +82.11%
on 06/05/25
15.42 -16.50%
on 02/17/26
+5.43 (+72.82%)
since 06/03/25

Most Recent Stories

More News
Amneal to Participate in Goldman Sachs 47th Annual Global Healthcare Conference 2026

BRIDGEWATER, N.J., June 01, 2026 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”), today announced that Chirag Patel, Co-Chief Executive and President,...

AMRX : 12.88 (+1.78%)
Q4 Earnings Highlights: Amneal (NASDAQ:AMRX) Vs The Rest Of The Generic Pharmaceuticals Stocks

Q4 Earnings Highlights: Amneal (NASDAQ:AMRX) Vs The Rest Of The Generic Pharmaceuticals Stocks

AMRX : 12.88 (+1.78%)
2 Reasons AMRX is Risky and 1 Stock to Buy Instead

2 Reasons AMRX is Risky and 1 Stock to Buy Instead

AMRX : 12.88 (+1.78%)
Amneal Reports First Quarter 2026 Financial Results

‒  Q1 2026 Net Revenue of $723 million ; GAAP Net Income of $62 million ; Diluted Income per Share of $0.19 ‒ ‒ Adjusted EBITDA of $202 million ; Adjusted Diluted EPS of...

AMRX : 12.88 (+1.78%)
1 Value Stock to Target This Week and 2 Facing Challenges

1 Value Stock to Target This Week and 2 Facing Challenges

WSBC : 33.61 (-2.78%)
CNXC : 27.68 (-2.84%)
AMRX : 12.88 (+1.78%)
Amneal (AMRX) Q1 Earnings Report Preview: What To Look For

Amneal (AMRX) Q1 Earnings Report Preview: What To Look For

AMRX : 12.88 (+1.78%)
Stocks Supported by Iran Ceasefire Extension and Strong Earnings

The S&P 500 Index ($SPX ) (SPY ) today is up +0.84%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.76%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.28%. June E-mini S&P futures (ESM26...

MSTR : 126.54 (-7.01%)
GOOGL : 358.99 (-0.79%)
UAL : 105.14 (-3.38%)
AAPL : 310.26 (-1.57%)
AVGO : 479.23 (-0.49%)
SNDK : 1,831.50 (+6.71%)
ADI : 437.67 (+3.42%)
GLXY : 28.49 (-1.96%)
NVR : 6,119.41 (-1.00%)
$IUXX : 30,571.24 (-0.29%)
COIN : 163.22 (-6.19%)
UNH : 377.00 (-0.24%)
Stocks Advance as US Extends Iran Ceasefire

The S&P 500 Index ($SPX ) (SPY ) today is up +0.65%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.70%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.79%. June E-mini S&P futures (ESM26...

MSTR : 126.54 (-7.01%)
UAL : 105.14 (-3.38%)
AVGO : 479.23 (-0.49%)
ADI : 437.67 (+3.42%)
GLXY : 28.49 (-1.96%)
TXN : 308.59 (+0.15%)
NVR : 6,119.41 (-1.00%)
$IUXX : 30,571.24 (-0.29%)
COIN : 163.22 (-6.19%)
ZNU26 : 109-170 (+0.07%)
ESM26 : 7,542.25 (-0.39%)
STX : 940.69 (+1.52%)
Kashiv BioSciences Agrees to Be Acquired by Amneal Pharmaceuticals to Create a Fully Integrated Global Biosimilar Leader

The proposed combination will create a differentiated global biosimilars platform that leverages Kashiv BioSciences’ development and manufacturing capabilities with Amneal Pharmaceuticals’ commercial...

AMRX : 12.88 (+1.78%)
Amneal: Q1 Earnings Snapshot

Amneal: Q1 Earnings Snapshot

AMRX : 12.88 (+1.78%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakest short term outlook on maintaining the current direction.

Relative Strength just crossed above 50%. The market is indicating support for a bullish trend.

See More Share

Business Summary

Amneal Pharmaceuticals LLC is an integrated specialty pharmaceutical company. It focused on developing, manufacturing and distributing generic, brand and biosimilar products. The company operates primarily in North America, Asia and Europe. Amneal Pharmaceuticals LLC, formerly known as Impax Laboratories...

See More

Key Turning Points

3rd Resistance Point 13.42
2nd Resistance Point 13.16
1st Resistance Point 13.02
Last Price 12.88
1st Support Level 12.61
2nd Support Level 12.35
3rd Support Level 12.21

See More

52-Week High 15.42
Last Price 12.88
Fibonacci 61.8% 12.23
Fibonacci 50% 11.24
Fibonacci 38.2% 10.26
52-Week Low 7.07

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.